Charlie Strange to Clinical Trials as Topic
This is a "connection" page, showing publications Charlie Strange has written about Clinical Trials as Topic.
Connection Strength
0.104
-
Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy. Int J Chron Obstruct Pulmon Dis. 2017; 12:135-140.
Score: 0.104
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.